These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 10463583

  • 1. Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo.
    Sasaki H, Niimi S, Akiyama M, Tanaka T, Hazato A, Kurozumi S, Fukushima S, Fukushima M.
    Cancer Res; 1999 Aug 15; 59(16):3919-22. PubMed ID: 10463583
    [Abstract] [Full Text] [Related]

  • 2. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
    Rose WC, Basler GA.
    In Vivo; 1990 Aug 15; 4(6):391-6. PubMed ID: 2103379
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K, Cowan KH, Sinha BK.
    Oncol Res; 1999 Aug 15; 11(3):153-9. PubMed ID: 10527075
    [Abstract] [Full Text] [Related]

  • 10. Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.
    Wang Z, Cai L, Wang H.
    Gynecol Oncol; 2005 Mar 15; 96(3):643-50. PubMed ID: 15721406
    [Abstract] [Full Text] [Related]

  • 11. Development of nonsymmetrical 1,4-disubstituted anthraquinones that are potently active against cisplatin-resistant ovarian cancer cells.
    Pors K, Plumb JA, Brown R, Teesdale-Spittle P, Searcey M, Smith PJ, Patterson LH.
    J Med Chem; 2005 Oct 20; 48(21):6690-5. PubMed ID: 16220985
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives.
    Moebus VJ, Stein R, Kieback DG, Runnebaum IB, Sass G, Kreienberg R.
    Anticancer Res; 1997 Oct 20; 17(2A):815-21. PubMed ID: 9137413
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H, Huq F, Yu JQ, Beale P, Fisher K.
    ChemMedChem; 2008 Jan 20; 3(1):145-51. PubMed ID: 17963210
    [Abstract] [Full Text] [Related]

  • 14. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 20; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin.
    Fukushima S, Kishimoto S, Takeuchi Y, Fukushima M.
    Adv Drug Deliv Rev; 2000 Dec 06; 45(1):65-75. PubMed ID: 11104898
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.